TrialNature communications2021
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.
Lars Ny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
117 papers cite itlatest 60 shown
this paperpooled ittrialcites it